Filing Flows › MiniMed Group (MMED) › Q2 2026
MiniMed Group (MMED) Q2 2026 earnings results (second quarter 2026)
10-Q filed Sep 8, 2026
MiniMed Group (MMED) reported revenue of $843M for the second quarter 2026 (Q2 2026), +17% from a year earlier and +0.7% from the quarter before. Operating margin was 0.6%, net earnings $0 (0.0% of revenue).
MiniMed Group, Q2 2026: revenue $843M (+17% year over year), operating margin 0.6%, net earnings $0, operating cash flow −$49.0M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $843M | +0.7% | +17% |
| Gross profit | $465M | -3% | +14% |
| Operating profit | $5.0M | — | — |
| Net earnings | $0 | — | — |
| Operating cash flow | −$49.0M | — | — |
What changed
Revenue was $843.0M in Q2 2026, up 17% year over year and up 1% from the previous quarter. CGM was the largest line at 51% of revenue. CGM added $71.0M year over year (up 20%), 59% of the total change. Other declined 53%.
Gross margin was 55.2%, down 1.4 points from a year earlier. Operating profit was $5.0M, a 0.6% margin (up 2.4 points year over year). Operating expenses grew 9% against revenue growth of 17%. The fastest-growing cost line was Other operating costs (+136%). Net earnings were $0K. The effective tax rate was 100.0%.
Operating cash flow was −$49.0M. Non-cash charges added back $41.0M of depreciation and amortization and $10.0M of share-based compensation. Working capital and other items used $100.0M. Capital expenditures of $41.0M exceeded it, leaving free cash flow of −$90.0M.
Questions
What was MiniMed Group's revenue in the second quarter 2026?
MiniMed Group (MMED) reported revenue of $843M for the second quarter 2026 (Q2 2026), +17% from a year earlier and +0.7% from the quarter before.
Was MiniMed Group profitable in the second quarter 2026?
Operating profit was $5.0M (0.6% of revenue) and net earnings $0.
Source: MiniMed Group 10-Q on SEC EDGAR.